AUB (based on CompreGyne) Flashcards

1
Q

What is the definition of oligomenorrhea?

A

Oligomenorrhea is defined as infrequent uterine bleeding with intervals between episodes varying from 35 days to 6 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is considered amenorrhea?

A

Amenorrhea is the absence of menses for at least 6 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the normal mean interval between menses?

A

The normal mean interval between menses is 28 days (±7 days).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What menstrual cycle intervals are considered abnormal?

A

Menstrual cycle intervals of 21 days or less or 35 days or more are considered abnormal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the normal mean duration of menstrual flow?

A

The normal mean duration of menstrual flow is 4 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many days of menstrual bleeding is considered abnormally prolonged?

A

Menstrual bleeding lasting longer than 7 days is considered abnormally prolonged.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the average menstrual blood loss (MBL)?

A

The average menstrual blood loss is 35 mL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What MBL is considered heavy menstrual bleeding?

A

Menstrual blood loss of 80 mL or greater is considered heavy menstrual bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What classification system is used to categorize the causes of abnormal uterine bleeding (AUB)?

A

The FIGO PALM-COEIN classification system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does PALM stand for in the PALM-COEIN system?

A

PALM stands for Polyp, Adenomyosis, Leiomyoma, and Malignancy/Hyperplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does COEIN stand for in the PALM-COEIN system?

A

COEIN stands for Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, and Not yet classified.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the notation system for AUB classification?

A

AUB is followed by PALM-COEIN with subscript 0 (absence) or 1 (presence) of the abnormality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are endometrial polyps composed of?

A

Endometrial polyps contain glands, stroma, and blood vessels covered with epithelium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What hormone is thought to play a key role in the development of endometrial polyps?

A

Estrogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What risk factors increase the likelihood of malignancy in endometrial polyps?

A

Symptomatic vaginal bleeding, postmenopausal status, tamoxifen use, and obesity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What imaging modality is used to detect small, asymptomatic endometrial polyps?

A

Transvaginal ultrasound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What condition is characterized by endometrial glands and stroma in the uterine myometrium?

A

Adenomyosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the most significant risk factor for adenomyosis?

A

Multiparity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What imaging findings are indicative of adenomyosis?

A

Enlarged, asymmetric uterus on ultrasound and thickening of the junctional zone ≥12 mm on MRI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are uterine leiomyomas also known as?

A

Fibroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What factor contributes to fibrosis in leiomyomas?

A

Transforming growth factor beta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How are leiomyomas classified based on location?

A

They are classified as intracavitary (type 0), submucosal (type 1 or 2), intramural, or subserosal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the most common presenting symptom of endometrial cancer?

A

Abnormal uterine bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What syndrome is associated with a high risk of endometrial cancer?

A

Lynch syndrome (hereditary nonpolyposis colorectal cancer).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are common coagulation disorders that may present as AUB?

A

Von Willebrand disease, hemophilia A and B, and inherited deficiencies of clotting factors V, VII, X, XI, XIII.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the primary cause of ovulatory dysfunction in adolescents?

A

Immaturity of the hypothalamic-pituitary-ovarian axis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the most common cause of anovulation in reproductive-age women?

A

Polycystic ovary syndrome (PCOS).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What hormonal imbalances can cause anovulatory bleeding?

A

Thyroid hormone abnormalities, hyperprolactinemia, and hypercortisolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What medications can cause iatrogenic AUB?

A

Hormonal contraceptives, selective estrogen receptor modulators, and gonadotropin-releasing hormone agonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What key historical details should be obtained from a woman presenting with abnormal uterine bleeding?

A

Frequency, duration, and amount of bleeding; changes in menstrual pattern; presence of oligomenorrhea, polymenorrhea, heavy menstrual bleeding, or intermenstrual bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How can women effectively track their abnormal uterine bleeding?

A

Using a calendar to record bleeding episodes or a smartphone application, though none are validated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What duration of symptoms defines chronic abnormal uterine bleeding?

A

Symptoms present for the majority of the preceding 6 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What duration of symptoms warrants investigation for abnormal uterine bleeding?

A

Symptoms lasting 3 months sufficiently indicate the need for investigation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Why is a woman’s estimate of blood loss unreliable?

A

There is poor correlation between estimated and actual blood loss due to variations in absorption by different sanitary products.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What objective criteria are used to determine menorrhagia?

A

Blood loss greater than 80 mL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What laboratory tests are useful for assessing menorrhagia?

A

Hemoglobin concentration, serum iron levels, serum ferritin levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What additional lab tests are useful in the initial workup of abnormal uterine bleeding?

A

β-hCG, TSH, PRL; androgen levels if PCOS is suspected.

38
Q

What lab tests should be ordered for adolescents with heavy menstrual bleeding and women with systemic disease?

A

CBC, platelet count, PT/PTT, von Willebrand factor, ristocetin cofactor.

39
Q

What historical clues suggest a coagulation disorder in a woman with heavy menstrual bleeding?

A

History of postpartum hemorrhage, surgical bleeding, dental bleeding, easy bruising, epistaxis, gum bleeding, family history of bleeding.

40
Q

What is the most common coagulation disorder associated with heavy menstrual bleeding?

A

Von Willebrand disease.

41
Q

What are the first steps in evaluating abnormal uterine bleeding in a woman with regular cycles?

A

Determine whether she is ovulating and assess risk factors for endometrial hyperplasia or malignancy.

42
Q

When is endometrial sampling indicated for abnormal uterine bleeding?

A

In women over 45 years old with heavy menstrual bleeding or those at risk for endometrial disease.

43
Q

What are the preferred methods for endometrial sampling?

A

Office-based Pipelle biopsy or dilation and curettage (D&C) if biopsy is inconclusive.

44
Q

What imaging modalities are used to assess the uterine cavity in abnormal uterine bleeding?

A

Sonohysterogram (SHG) or flexible hysteroscopy.

45
Q

Why is MRI preferred over ultrasound for evaluating fibroids?

A

MRI provides superior assessment of fibroid position, size, number, and myometrial invasion.

46
Q

What is the primary treatment for endometrial polyps causing abnormal uterine bleeding?

A

Surgical removal via hysteroscopy.

47
Q

What are the medical treatment options for abnormal uterine bleeding?

A

Estrogens, progestogens, NSAIDs, antifibrinolytic agents, GnRH agonists.

48
Q

What is the preferred initial treatment for adolescents with anovulatory bleeding?

A

Cyclic progestogen (e.g., medroxyprogesterone acetate, 10 mg for 10 days each month).

49
Q

What is the preferred treatment for perimenopausal women with abnormal uterine bleeding?

A

Low-dose oral contraceptives (20 μg) in nonsmoking women.

50
Q

What are the treatment options for chronic anovulatory bleeding?

A

Oral contraceptives or cyclic progestogens; ovulation induction if conception is desired.

51
Q

What is the treatment goal for women with AUB-E (abnormal uterine bleeding of endometrial origin)?

A

Reduce excessive bleeding using progestogens, oral contraceptives, or levonorgestrel intrauterine system (LNG-IUS).

52
Q

What are the benefits of the levonorgestrel-releasing intrauterine system (LNG-IUS) in AUB?

A

Reduces menstrual blood loss by up to 100% in 1 year, increases hemoglobin, decreases dysmenorrhea, and is effective for fibroids and adenomyosis.

53
Q

What is the mechanism of NSAIDs in reducing menstrual blood loss?

A

Inhibits prostaglandin synthesis, reducing endometrial blood flow.

54
Q

What NSAIDs have been shown to reduce menstrual blood loss?

A

Mefenamic acid, ibuprofen, meclofenamate sodium, naproxen sodium.

55
Q

What is the role of antifibrinolytic agents in the management of heavy menstrual bleeding?

A

They inhibit fibrinolysis, reducing blood loss by approximately 50%.

56
Q

What antifibrinolytic agents are commonly used for menorrhagia?

A

Tranexamic acid, ε-aminocaproic acid (EACA), para-aminomethyl benzoic acid (PAMBA).

57
Q

When are antifibrinolytic agents contraindicated?

A

In patients with renal failure, pregnancy, or history of thrombosis.

58
Q

What is a major risk of combining tranexamic acid with oral contraceptives?

A

Increased risk of thrombosis and myocardial infarction.

59
Q

What is the quickest way to stop acute bleeding in a hemodynamically unstable woman?

60
Q

What is the preferred approach for older women or those with medical risk factors who cannot tolerate high-dose hormonal therapy?

61
Q

What is the most effective pharmacologic regimen to stop acute bleeding that does not require curettage?

A

High-dose estrogen

62
Q

Why is high-dose estrogen effective in stopping acute bleeding?

A

Estrogen in pharmacologic doses causes rapid endometrial growth, covering denuded epithelial surfaces.

63
Q

What is the recommended dose of oral conjugated equine estrogen (CEE) for acute bleeding?

A

10 mg/day in four divided doses

64
Q

How might high-dose CEE alter platelet activity?

A

It may promote platelet adhesiveness and reduce bleeding time.

65
Q

What is the advantage of IV estrogen over oral estrogen for acute bleeding?

A

IV estrogen has a more rapid onset, but no significant advantage over oral estrogen if tolerated.

66
Q

What should be considered if bleeding does not decrease within the first 24 hours of high-dose estrogen therapy?

A

An organic cause, and curettage should be considered.

67
Q

Why is progestogen added after initial estrogen therapy for acute bleeding?

A

Most cases of acute heavy bleeding result from anovulation, requiring progestogen to stabilize the endometrium.

68
Q

What is the typical progestogen regimen following estrogen therapy for acute bleeding?

A

Medroxyprogesterone acetate (MPA) 10 mg once daily for 7-10 days.

69
Q

What is an alternative to sequential high-dose estrogen-progestin therapy for acute bleeding?

A

Combination oral contraceptives (OCs) containing both estrogen and progestin.

70
Q

What is the typical dosing regimen of combination OCs for acute bleeding?

A

Four tablets per day in divided doses until bleeding stops, then continued for at least 1 week.

71
Q

Why might high-dose estrogen therapy be contraindicated in some women?

A

Prior thrombosis, certain rheumatologic diseases, or estrogen-responsive cancers.

72
Q

When is estrogen therapy more logical for prolonged heavy bleeding?

A

If ultrasound shows a thin endometrial stripe (<5 mm).

73
Q

When should curettage be considered in cases of heavy bleeding?

A

If the endometrium is thick (>10-12 mm) or if an anatomic finding is suspected.

74
Q

What is the role of progestogens in the management of acute bleeding?

A

They stop endometrial growth and promote an organized slough of the endometrium.

75
Q

What is the typical dosing regimen for high-dose progestogens in acute bleeding?

A

MPA 60 mg/day (20 mg three times daily) for 7 days, then 20 mg/day for 3 weeks.

76
Q

Which progestogen regimen has shown similar efficacy to combination OCs in stopping acute bleeding?

A

MPA 60 mg/day for 7 days, then 20 mg/day for 3 weeks.

77
Q

What is the mechanism of action of progestogens in stopping acute bleeding?

A

They stabilize the endometrium and increase the PGF2α/PGE ratio, promoting vasoconstriction.

78
Q

What synthetic androgen has been used for the treatment of heavy menstrual bleeding?

79
Q

What are the main limitations of danazol for treating heavy menstrual bleeding?

A

Significant side effects such as weight gain and skin problems.

80
Q

What is the quickest surgical method to stop acute bleeding in hypovolemic women?

A

Dilation and curettage (D&C).

81
Q

When is D&C indicated for acute bleeding?

A

For hypovolemic women and older women at high risk for endometrial neoplasia.

82
Q

Is D&C curative for anovulatory bleeding?

A

Rarely, as it does not address the underlying pathophysiology.

83
Q

What is an alternative surgical treatment for abnormal bleeding when medical therapy fails?

A

Endometrial ablation (EA).

84
Q

What are contraindications to endometrial ablation?

A

Very large uteri, endometrial hyperplasia, or cancer.

85
Q

Why is pretreatment with danazol or a GnRH agonist beneficial before endometrial ablation?

A

It thins the endometrium, improving success rates.

86
Q

Which women have a higher risk of requiring hysterectomy after endometrial ablation?

A

Those with dysmenorrhea, prior cesarean section, or structural abnormalities.

87
Q

What is the leading cause of hysterectomy in the U.S.?

A

Abnormal uterine bleeding (AUB).

88
Q

What are the indications for hysterectomy in AUB?

A

Failure of medical therapy, contraindications to medical therapy, or excessive menstrual blood loss.

89
Q

Which surgical option is preferred when fibroids are causing excessive bleeding?

A

Uterine artery embolization (UAE).

90
Q

What is the recommended treatment for adolescents with heavy menstrual bleeding?

A

MPA 10 mg/day for 10 days each month for at least 3 months.

91
Q

What is the best long-term treatment for anovulatory abnormal bleeding?

A

Oral contraceptives (OCs) or cyclic progestogens.

92
Q

Which treatment is most effective for chronic ovulatory heavy menstrual bleeding if no anatomic abnormalities are present?

A

Low-dose OCs.